abciximab

(pharmacology) A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the F_(ab) fragment from a chimeric monoclonal antibody prepared from humans and mice.